Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Nov 18, 2020 10:51am
80 Views
Post# 31922009

RE:RE:Market pressure

RE:RE:Market pressureGotta agree that those who got in for the COVID angle could be getting out.  Unlikely insiders as over the past so many years, hardly any buys or sells.

Keep in mind that the use of an inhalable therapeutic for COVID was a "detour", still many applications for this. There will be those who refuse to take a COVID vaccine who can benefit in an inhalable Y-BG therapeutic if proven successful.

prophetoffacts wrote: Market pressure
large orders on the sell side - a bad sign?!"


COVID vaccines are demonstrating ~95% efficacy; including in the vulnerable elderly population. CZO has been focused recently on a COVID therapeutic; however its technology more broadly applicable.


<< Previous
Bullboard Posts
Next >>